Dr. Kartick Rastogi Specialist in Radiation Oncology

Introduction

Dr. Kartick Rastogi is an experienced radiation oncologist, with over 8 years of experience in managing a wide range of cancers. He is an expert in administering radiation therapy through various approaches such as linear accelerator, brachytherapy and cobalt teletherapy. He is a member of numerous reputed associations such as Atomic Energy Regulatory Board (AERB), Gujarat Medical Council (GMC), Rajasthan Medical Council (RMC), European Society of Medical Oncology (ESMO) and Association of Radiation Oncologists of India (AROI).

Area of Expertise

Dr. Kartick Rastogi is a highly skilled and experienced consultant – radiation oncology practising at HCG Cancer Centre, Jaipur.
He has over 8 years of experience in the radiation management of a broad spectrum of cancers.
Dr. Kartick is an expert at administering radiation therapy through the following approaches:
Linear Accelerator: Varian Trilogy FFF Linear Accelerator, Varian Clinac iX 2300CD Linear Accelerator, Elekta Synergy Linear Accelerator,Siemens Oncor Expression Linear Accelerator
Brachytherapy: Eckert & Ziegler BEBIG Cobalt Brachytherapy, Varian GammaMedplus iX Iridium Brachytherapy, microSelectron (Elekta) Iridium Brachytherapy
Cobalt Teletherapy: Bhabhatron-II TeleCobalt Machine, ATC-C9 Telecobalt Machine

Research & Publications

Dosimetric comparison of IMRT versus 3DCRT for post mastectomy chest wall irradiation. Radiat Oncol J 2018;36:71-8.
(PMID: 29621872, PMCID: PMC5903359) (38 Citations)
A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia Pac J OncolNurs 2018;5:107-13.(PMID: 29379842, PMCID: PMC5763427) (22 Citations)
Palliation of brain metastases: Analysis of prognostic factors affecting overall survival.
Indian J Palliat Care 2018;24:308-12. (PMID: 30111944, PMCID: PMC6069611) (19 Citations)
Breast cancer‑related lymphedema in postmastectomy patients receiving adjuvant irradiation: A prospective study. Indian J Cancer 2018;55:184-9. (PMID: 30604734) (6 Citation)
Symptom palliation in patients with bone metastases treated with radiotherapy. Indian J Med Paediatr Oncol 2019;40:265-9. (PMID: awaited, PMCID: awaited)
Depression in cancer patients: Magnitude of problem and factors responsible. Indian J Med Paediatr Oncol 2019;40:542-6. (PMID: awaited, PMCID: awaited)
Primary rectal lymphoma with synchronous liver involvement: An extremely rare case report. Indian J Med Paediatr Oncol 2020;41:93-5. (PMID: awaited, PMCID: awaited)
Nasal cavity cancer with distal phalanx metastasis: An extremely rare case report. Indian J Med Paediatr Oncol 2019;40:s117-9. (PMID: awaited, PMCID: awaited)
Association of Treatment Outcome of Tuberculosis with type of Category of Tuberculosis. International Multispecialty Journal of Health 2015;1:6-9.
Compliance to radiotherapy: A tertiary care centre experience. Indian J Cancer 2018;55:166-9. (PMID: 30604730) (17 Citations)
A study of hormone receptor status in breast carcinoma and use of HER2 targeted therapy in a tertiary care centre of India.
Indian J Med Paediatr Oncol 2019;40:s54-60. (PMID: awaited, PMCID: awaited) (2 Citation)
Tumour bleeding: Efficacy and outcome of haemostatic radiotherapy. Natl Med J India 2019;32:342-4.
(PMID 33380626)
Compliance, Toxicity & Survival function analysis of Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck treated with definitive Radiotherapy Concurrent with weekly Cisplatin.
J Biol Engg Res & Rev 2017; 4:7-12.
A Comparative Study of Weekly

Other Doctors